Chronic Migraine — CGRP Inhibition, Autonomic Function, and Migraine
Citation(s)
Bates D et al Fitting Linear Mixed-Effects Models Using lme4. Journal of Statistical Software 2015; 67, 1: 1-48. https://doi.org/10.18637/jss.v067.i01.
Buijs RM, Escobar C, Swaab DF The circadian system and the balance of the autonomic nervous system. Handb Clin Neurol. 2013;117:173-91. doi: 10.1016/B978-0-444-53491-0.00015-8.
Cambron M, Maertens H, Paemeleire K, Crevits L Autonomic function in migraine patients: ictal and interictal pupillometry. Headache. 2014 Apr;54(4):655-62. doi: 10.1111/head.12139. Epub 2013 Jun 28.
Ewing DJ, Martyn CN, Young RJ, Clarke BF The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985 Sep-Oct;8(5):491-8. doi: 10.2337/diacare.8.5.491.
Feuerstein M, Bush C, Corbisiero R Stress and chronic headache: a psychophysiological analysis of mechanisms. J Psychosom Res. 1982;26(2):167-82. doi: 10.1016/0022-3999(82)90034-4.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8. Erratum In: Lancet. 2019 Jun 22;393(10190):e44.
Hansen JM, Schankin CJ Cerebral hemodynamics in the different phases of migraine and cluster headache. J Cereb Blood Flow Metab. 2019 Apr;39(4):595-609. doi: 10.1177/0271678X17729783. Epub 2017 Aug 31.
He H, Chai J, Zhang S, Ding L, Yan P, Du W, Yang Z CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation. Mol Med Rep. 2016 May;13(5):3977-84. doi: 10.3892/mmr.2016.5023. Epub 2016 Mar 21.
Holzmann B Antiinflammatory activities of CGRP modulating innate immune responses in health and disease. Curr Protein Pept Sci. 2013 Jun;14(4):268-74. doi: 10.2174/13892037113149990046.
Kee Z, Kodji X, Brain SD The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects. Front Physiol. 2018 Sep 19;9:1249. doi: 10.3389/fphys.2018.01249. eCollection 2018.
Ko JA, Mizuno Y, Ohki C, Chikama T, Sonoda KH, Kiuchi Y Neuropeptides released from trigeminal neurons promote the stratification of human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):125-33. doi: 10.1167/iovs.13-12642.
Messina R, Filippi M, Goadsby PJ Recent advances in headache neuroimaging. Curr Opin Neurol. 2018 Aug;31(4):379-385. doi: 10.1097/WCO.0000000000000573.
Miglis MG Migraine and Autonomic Dysfunction: Which Is the Horse and Which Is the Jockey? Curr Pain Headache Rep. 2018 Feb 23;22(3):19. doi: 10.1007/s11916-018-0671-y.
Novak P Quantitative autonomic testing. J Vis Exp. 2011 Jul 19;(53):2502. doi: 10.3791/2502.
Peng KP, May A Redefining migraine phases - a suggestion based on clinical, physiological, and functional imaging evidence. Cephalalgia. 2020 Jul;40(8):866-870. doi: 10.1177/0333102419898868. Epub 2020 Jan 13.
Pogacnik T, Sega S, Pecnik B, Kiauta T Autonomic function testing in patients with migraine. Headache. 1993 Nov-Dec;33(10):545-50. doi: 10.1111/j.1526-4610.1993.hed3310545.x.
R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2014). URL http://www.R-project.org/
Rauschel V, Straube A, Suss F, Ruscheweyh R Responsiveness of the autonomic nervous system during paced breathing and mental stress in migraine patients. J Headache Pain. 2015;16:82. doi: 10.1186/s10194-015-0567-8. Epub 2015 Sep 16.
Robbins L CGRP Antagonists: Physiologic Effects and Serious Side Effects. Headache. 2018 Oct;58(9):1469-1471. doi: 10.1111/head.13408. Epub 2018 Oct 11. No abstract available.
Robertson CE Could CGRP Antagonists Be Helpful in the Fight Against COVID-19? Headache. 2020 Jul;60(7):1450-1452. doi: 10.1111/head.13853. Epub 2020 Jun 15. No abstract available.
Sacks O Migraine: The evolution of a common disorder. 1st ed. Univ of California Press, 1970, p. 53-205.
SAS Institute Inc Base SASĀ® 9.4 Procedures Guide. Cary, NC: SAS Institute Inc. (2011). URL: http://documentation.sas.com/?docsetId=acadbas&docsetTarget =acadbas.pdf&docsetVersion=9.4&locale=en
Schulte LH, May A The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016 Jul;139(Pt 7):1987-93. doi: 10.1093/brain/aww097. Epub 2016 May 5.
Tepper SJ Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018. Headache. 2018 Nov;58 Suppl 3:276-290. doi: 10.1111/head.13417.
Treister R, O'Neil K, Downs HM, Oaklander AL Validation of the composite autonomic symptom scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy. Eur J Neurol. 2015 Jul;22(7):1124-30. doi: 10.1111/ene.12717. Epub 2015 Apr 23.
Tringali G, Navarra P Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis. Peptides. 2019 Jun;116:16-21. doi: 10.1016/j.peptides.2019.04.012. Epub 2019 Apr 21.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.